PR Newswire: news distribution, targeting and monitoring
Dec 24 2014

"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients

OTTAWA, Dec. 24, 2014 /CNW/ -   The issue: "Jetfuel Superburn" is being recalled after Health Canada tests confirmed it contains two...

Dec 24 2014

Straighten Your Teeth in the New Year with Invisalign Treatments Now Offered by Dr. Shindler

 Agoura Hills dentist, Dr. Philip Shindler, now offers different Invisalign treatment options to meet various needs. Invisalign offers a unique...

Dec 24 2014

CBD Pure Crystallite, Removes Troubles of CBD Oil from Paste, usCBDpur, LLC Announces New 99%+

usCBDpur, the importer/exporter as well as majority supplier of this new pure CBD isolate, has announced the results of a recent study,...

Dec 24 2014

PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering

PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI, PTBIW), a biopharmaceutical company advancing patient care in critical areas, announced the...

Dec 24 2014

IMRIS Announces Closing of Private Placement Offering of Units

MINNEAPOLIS, Dec. 24, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced it has closed the...

Dec 24 2014

United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval...

Dec 24 2014

ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC

 The International Trade Commission (ITC) issued its final decision in the case brought by ResMed (RMD) against BMC Medical. In a notice issued...

Dec 24 2014

Soligenix Announces Closing of Public Offering of Units

Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical...

Dec 24 2014

Vermillion Announces Closing of Equity Financing

 Vermillion, Inc. (Nasdaq:  VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that the Company...

Dec 24 2014

Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study

Kinex Pharmaceuticals announced today that the first patient has been dosed with KX2-361 at Roswell Park Cancer Institute. KX2-361 (KX02), a dual...

Dec 24 2014

China Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Improvements in intellectual property protection, an ageing population and increasing access to healthcare will drive the robust growth...

Dec 24 2014

Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association

 Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, is proud to announce Jennifer Hagerman, Pharm.D.,...

Dec 24 2014

3D Cell Cultures: Technologies and Global Markets

REPORT HIGHLIGHTS The three dimensional cell culture market was $438 million in 2013. This market is expected to grow to $586.1 million and about...

Dec 24 2014

Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board

 Conkwest, Inc., the Natural Killer Cell Company of the West, developing the proprietary Natural Killer (NK) cell-line platform,...

Dec 24 2014

Regal Medical Group Promotes Free Diabetes Clinic For Members

 Regal Medical Group (RMG) today announced its Simi Valley Diabetes Clinic, offering free diabetes care for members, has helped more than 200...

Dec 24 2014

Gene Therapy Partnering Terms and Agreements

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into...

Dec 24 2014

Osteoporosis Drugs Markets in China

China's demand for Osteoporosis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to...

Dec 24 2014

Actavis and Adamas Announce FDA Approval of Namzaric™, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride

 Actavis plc (NYSE: ACT) and Adamas Pharmaceuticals Inc. (NASDAQ: ADMS) today announced that the U.S. Food and Drug Administration (FDA) has...

Dec 24 2014

Orthopedic Trauma Fixation Devices Market - Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020

The global orthopedic trauma fixation devices market is witnessing significant growth due to increasing incidence of fractures and lack of...

Dec 24 2014

Market Snapshot: Mammography Systems 2006 to 2020 - Asia-Pacific (China, Japan, South Korea, Australia and India)

Market Snapshot: Mammography Systems 2006 to 2020 - Asia-Pacific (China, Japan, South Korea, Australia and India) Summary GBI Research's report,...

Search
  
  1. Bloggers
  2. News Unfiltered
  3. Blog Posts
  4. Blogger Services
  5. Blogger Events
  6. Contact Us